These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 7737956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 4. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV, Sternić NM, Filipović SR, Vojvodić NM, Kostić VS.
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C, Bret P, Bret MC, Queuille E.
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Management of treatment-resistant patients with schizophrenia.
    Marder SR.
    J Clin Psychiatry; 1996 Sep; 57 Suppl 11():26-30. PubMed ID: 8941168
    [Abstract] [Full Text] [Related]

  • 11. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 12. Management of late-life psychosis.
    Jeste DV, Eastham JH, Lacro JP, Gierz M, Field MG, Harris MJ.
    J Clin Psychiatry; 1996 Apr; 57 Suppl 3():39-45; discussion 49-50. PubMed ID: 8626369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clozapine maintenance therapy in schizophrenia.
    Gaszner P, Makkos Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [Abstract] [Full Text] [Related]

  • 15. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S, Katz G, Zislin Z, Knobler HY, Durst R.
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [Abstract] [Full Text] [Related]

  • 16. [Clinical effects of clozapine: effect on negative symptoms].
    Llorca PM, Lançon C, Auquier P, Bougerol T.
    Encephale; 1996 Apr; 22(4):287-92. PubMed ID: 9035984
    [Abstract] [Full Text] [Related]

  • 17. [Clozapine (Leponex) in France].
    Péré JJ, Chaumet-Riffaud PD, Bourdeix I, Bourdain M.
    Encephale; 1992 Sep; 18 Spec No 3():427-32. PubMed ID: 1339758
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M, Kuwilsky A, Krumm B, Dressing H.
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [Abstract] [Full Text] [Related]

  • 19. The efficacy, safety, and tolerability of antipsychotics in the elderly.
    Maixner SM, Mellow AM, Tandon R.
    J Clin Psychiatry; 1999 May; 60 Suppl 8():29-41. PubMed ID: 10335669
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.